BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 14642796)

  • 1. The cyclo-oxygenase-2 inhibitor, rofecoxib, attenuates mucosal damage due to colitis induced by trinitrobenzene sulphonic acid in rats.
    Martín AR; Villegas I; La Casa C; Alarcón de la Lastra C
    Eur J Pharmacol; 2003 Nov; 481(2-3):281-91. PubMed ID: 14642796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of simultaneous inhibition of cyclooxygenase-2 and inducible nitric oxide synthase in experimental colitis in rats.
    Dudhgaonkar SP; Tandan SK; Kumar D; Raviprakash V; Kataria M
    Inflammopharmacology; 2007 Oct; 15(5):188-95. PubMed ID: 17943250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of specific inhibition of cyclo-oxygenase-1 and cyclo-oxygenase-2 in the rat stomach with normal mucosa and after acid challenge.
    Gretzer B; Maricic N; Respondek M; Schuligoi R; Peskar BM
    Br J Pharmacol; 2001 Apr; 132(7):1565-73. PubMed ID: 11264251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The COX-2 inhibitor, rofecoxib, ameliorates dextran sulphate sodium induced colitis in mice.
    Martín AR; Villegas I; Alarcón de la Lastra C
    Inflamm Res; 2005 Apr; 54(4):145-51. PubMed ID: 15883736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Celecoxib, a selective cyclo-oxygenase-2 inhibitor reduces the severity of experimental colitis induced by dinitrobenzene sulfonic acid in rats.
    Cuzzocrea S; Mazzon E; Serraino I; Dugo L; Centorrino T; Ciccolo A; Sautebin L; Caputi AP
    Eur J Pharmacol; 2001 Nov; 431(1):91-102. PubMed ID: 11716847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of endogenous nitric oxide activity impairs the colonic sparing effect of rofecoxib, the cyclooxygenase-2 inhibitor and resveratrol, the preferential cyclooxygenase-1 inhibitor in the course of experimental colitis. Role of oxidative stress biomarkers and proinflammatory cytokines.
    Kwiecień S; Wojcik-Grzybek D; Sliwowski Z; Targosz A; Chmura A; Magierowska K; Strzalka M; Glowacka U; Ptak-Belowska A; Magierowski M; Brzozowski T
    J Physiol Pharmacol; 2023 Oct; 74(5):. PubMed ID: 38085520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PARP inhibition reduces acute colonic inflammation in rats.
    Sánchez-Fidalgo S; Villegas I; Martín A; Sánchez-Hidalgo M; Alarcón de la Lastra C
    Eur J Pharmacol; 2007 Jun; 563(1-3):216-23. PubMed ID: 17374531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Healing impairment effect of cyclooxygenase inhibitors on dextran sulfate sodium-induced colitis in rats.
    Tsubouchi R; Hayashi S; Aoi Y; Nishio H; Terashima S; Kato S; Takeuchi K
    Digestion; 2006; 74(2):91-100. PubMed ID: 17143008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of dosmalfate, a new cytoprotective agent, on acute and chronic trinitrobenzene sulphonic acid-induced colitis in rats.
    Villegas I; La Casa C; Orjales A; Alarcón de la Lastra C
    Eur J Pharmacol; 2003 Jan; 460(2-3):209-18. PubMed ID: 12559383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Up-regulation of cyclooxygenase-2 by inhibition of cyclooxygenase-1: a key to nonsteroidal anti-inflammatory drug-induced intestinal damage.
    Tanaka A; Hase S; Miyazawa T; Takeuchi K
    J Pharmacol Exp Ther; 2002 Mar; 300(3):754-61. PubMed ID: 11861778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of cyclooxygenase (COX)-1 and COX-2 inhibition in nonsteroidal anti-inflammatory drug-induced intestinal damage in rats: relation to various pathogenic events.
    Tanaka A; Hase S; Miyazawa T; Ohno R; Takeuchi K
    J Pharmacol Exp Ther; 2002 Dec; 303(3):1248-54. PubMed ID: 12438549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of a selective nonsteroidal anti-inflammatory inhibitor of cyclooxygenase-2 on the small bowel of rats.
    Leite AZ; Sipahi AM; Damião AO; Garcez AT; Buchpiguel CA; Lopasso FP; Lordello ML; Agostinho CL; Laudanna AA
    Braz J Med Biol Res; 2004 Mar; 37(3):333-6. PubMed ID: 15060699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclooxygenase-2-derived prostaglandin D(2) is an early anti-inflammatory signal in experimental colitis.
    Ajuebor MN; Singh A; Wallace JL
    Am J Physiol Gastrointest Liver Physiol; 2000 Jul; 279(1):G238-44. PubMed ID: 10898767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibiotic treatment with ampicillin accelerates the healing of colonic damage impaired by aspirin and coxib in the experimental colitis. Importance of intestinal bacteria, colonic microcirculation and proinflammatory cytokines.
    Zwolinska-Wcislo M; Krzysiek-Maczka G; Ptak-Belowska A; Karczewska E; Pajdo R; Sliwowski Z; Urbanczyk K; Drozdowicz D; Konturek SJ; Pawlik WW; Brzozowski T
    J Physiol Pharmacol; 2011 Jun; 62(3):357-68. PubMed ID: 21893697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acetic acid-derived prostaglandin-dependent colonic adaptive cytoprotection is preserved in chronic colitis: role of cyclo-oxygenase.
    Ohara K; Kono T; Chisato N; Asama T; Yoneda M; Kasai S
    Int J Colorectal Dis; 2003 May; 18(3):260-6. PubMed ID: 12673493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rosiglitazone, a PPARgamma ligand, modulates signal transduction pathways during the development of acute TNBS-induced colitis in rats.
    Sánchez-Hidalgo M; Martín AR; Villegas I; de la Lastra CA
    Eur J Pharmacol; 2007 May; 562(3):247-58. PubMed ID: 17343846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An oral drug delivery system targeting immune-regulating cells ameliorates mucosal injury in trinitrobenzene sulfonic acid-induced colitis.
    Nakase H; Okazaki K; Tabata Y; Uose S; Ohana M; Uchida K; Nishi T; Debreceni A; Itoh T; Kawanami C; Iwano M; Ikada Y; Chiba T
    J Pharmacol Exp Ther; 2001 Jun; 297(3):1122-8. PubMed ID: 11356937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro study of tocolytic effect of rofecoxib, a specific cyclo-oxygenase 2 inhibitor. Comparison and combination with other tocolytic agents.
    Doret M; Mellier G; Benchaib M; Piacenza JM; Gharib C; Pasquier JC
    BJOG; 2002 Sep; 109(9):983-8. PubMed ID: 12269693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rofecoxib produces intestinal but not gastric damage in the presence of a low dose of indomethacin in rats.
    Yokota A; Taniguchi M; Takahira Y; Tanaka A; Takeuchi K
    J Pharmacol Exp Ther; 2005 Jul; 314(1):302-9. PubMed ID: 15831440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concurrent infection with Schistosoma mansoni attenuates inflammation induced changes in colonic morphology, cytokine levels, and smooth muscle contractility of trinitrobenzene sulphonic acid induced colitis in rats.
    Moreels TG; Nieuwendijk RJ; De Man JG; De Winter BY; Herman AG; Van Marck EA; Pelckmans PA
    Gut; 2004 Jan; 53(1):99-107. PubMed ID: 14684583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.